MedPath

KinDex Pharmaceuticals, Inc.

KinDex Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2009-01-01
Employees
1
Market Cap
-
Website
http://kindexpharmaceuticals.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects

Phase 2
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2015-05-15
Last Posted Date
2017-10-20
Lead Sponsor
KinDex Pharmaceuticals, Inc.
Target Recruit Count
9
Registration Number
NCT02444910
Locations
🇺🇸

University of Kentucky's Center for Clinical and Translational Science (CCTS), Lexington, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.